HUMA   $5.2  -4.59% Market Closed After Close 5.3483 2.85%

Humacyte Inc
Total Cash 93.56M
totalCashPerShare 0.784
EBITDA -99.65M
Total Debt 18.93M
quickRatio 5.269
currentRatio 5.413
Total Revenue
debtToEquity
Revenue/Share
ROA -0.43605
ROE -8.50807
grossProfits
freeCashflow -49.98M
operatingCashflow -80.70M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 598.51M
forwardPE -6.143837
floatShares 84.80M
sharesOutstanding 119.35M
sharesShort 11.27M
sharesShortPriorMonth 12.01M
dateShortInterest
sharesPercentSharesOut 0.09%
heldPercentInsiders 0.29%
heldPercentInstitutions 0.27%
Short Ratio help_outline 3.51%
shortPercentOfFloat 0.12%
impliedSharesOutstanding
bookValue -0.237
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -139.66M
trailingEps -1.27%
forwardEps -0.86%
enterpriseToEbitda -6.01
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.25 3Q 2024
institutionsCount 165
lastUpdated Sept. 16, 2024, 8:33 p.m.